XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 160 filers reported holding XENON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,362,744 | -6.3% | 69,167 | +5.6% | 0.00% | – |
Q2 2023 | $2,521,097 | +15.5% | 65,483 | +7.3% | 0.00% | – |
Q1 2023 | $2,183,298 | -8.0% | 61,003 | +1.3% | 0.00% | – |
Q4 2022 | $2,374,356 | +29.3% | 60,217 | +18.3% | 0.00% | – |
Q3 2022 | $1,837,000 | +25.8% | 50,891 | +6.0% | 0.00% | – |
Q2 2022 | $1,460,000 | +6.7% | 47,996 | +7.2% | 0.00% | – |
Q1 2022 | $1,368,000 | -13.4% | 44,776 | -11.5% | 0.00% | – |
Q4 2021 | $1,580,000 | +172.9% | 50,596 | +33.7% | 0.00% | – |
Q3 2021 | $579,000 | -30.4% | 37,850 | -15.4% | 0.00% | – |
Q2 2021 | $832,000 | -8.0% | 44,721 | -11.6% | 0.00% | – |
Q1 2021 | $904,000 | +26.1% | 50,562 | +8.5% | 0.00% | – |
Q4 2020 | $717,000 | +3.9% | 46,622 | -25.2% | 0.00% | – |
Q3 2020 | $690,000 | -10.6% | 62,353 | +1.2% | 0.00% | – |
Q2 2020 | $772,000 | +16.3% | 61,635 | +5.2% | 0.00% | – |
Q1 2020 | $664,000 | +14.7% | 58,599 | +32.7% | 0.00% | – |
Q4 2019 | $579,000 | +70.8% | 44,143 | +17.3% | 0.00% | – |
Q3 2019 | $339,000 | -8.6% | 37,636 | 0.0% | 0.00% | – |
Q2 2019 | $371,000 | +50.8% | 37,636 | +55.5% | 0.00% | – |
Q1 2019 | $246,000 | +219.5% | 24,202 | +97.6% | 0.00% | – |
Q4 2018 | $77,000 | -43.4% | 12,246 | +18.9% | 0.00% | – |
Q3 2018 | $136,000 | – | 10,298 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |